Thor Medical - Issuance of RSU shares to members of the board
Thor Medical ASA (TRMED) · publisert 2025-11-11 22:15 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass | Tolket via |
|---|---|---|---|---|---|---|---|---|
| John Andersen | Person discharging managerial responsibilities Member of the board of directors | other | 344 518 | 0,2 NOK | 2025-11-11 | NO0010597883 | Outside trading venue NOTIFICATION OF TRANSACTIONS PURSUANT TO THE MARKET ABUSE REGULATION ARTICLE 19 | rules |
| Mimi Kristine Berdal | Person discharging managerial responsibilities Member of the board of directors | other | 344 518 | 0,2 NOK | 2025-11-11 | NO0010597883 | Outside trading venue | rules |
| John Andersen | Person discharging managerial responsibilities Member of the board of directors | disposal | 344 518 | 3,615 NOK | 2025-11-11 | NO0010597883 | Outside trading venue NOTIFICATION OF TRANSACTIONS PURSUANT TO THE MARKET ABUSE REGULATION ARTICLE 19 | rules |
| Scatec Innovation AS nærstående | Person closely associated with a person discharging managerial responsibilities Board member John Andersen of Thor Medical ASA is CEO of the closely associated person | acquisition | 344 518 | 3,615 NOK | 2025-11-11 | NO0010597883 | Outside trading venue | rules |
Vedlegg
- Download announcement as PDF.pdf (tekst hentet ut)
- 20251111 - TRMED - MAR forms RSU share issue 2025.pdf (tekst hentet ut)
- 20251111 - TRMED - MAR forms Scatec Innovations_John Andersen RSU share transfer.pdf (tekst hentet ut)
Meldingstekst
11.11.2025 23:15:10 CET | Thor Medical ASA | Mandatory notification of trade
primary insiders
Reference is made to the stock exchange announcement made by Thor Medical ASA,
the "Company") on 21 April 2024 regarding grant of restricted share units
("RSU") to the members of the board.
The Company's board of directors has today resolved to issue 1,090,974 new
shares in the Company pursuant to the RSU-program. Current board members, John
Andersen and Mimi Kristine Berdal, have each been issued 344,518 new shares.
John Andersen has agreed to transfer all 344,518 shares to Scatec Innovation AS,
where John Andersen is the CEO, a close associate of a primary insider of the
Company.
Notifications of the transaction in accordance with the Market Abuse Regulation
Article 19 are attached with this announcement.
CONTACTS
* Brede Ellingsæter, CFOO, Thor Medical ASA, +47 472 38 440,
brede.ellingseter@thormedical.com
ABOUT THOR MEDICAL ASA
Thor Medical is an emerging supplier of radionuclides, primarily alpha particle
emitters, from naturally occurring thorium. Its proprietary production process
requires no irradiation or use of nuclear reactors, and provides reliable,
environmentally friendly, cost-efficient supply of alpha-emitters for the
radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and
listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'.
To learn more, visitwww.thormedical.com - https://www.thormedical.com.
ATTACHMENTS
Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/18716187/6556/Download%20announce
ment%20as%20PDF.pdf
20251111 - TRMED - MAR forms RSU share issue 2025.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/18716187/6554/20251111%20-%20TRME
D%20-%20MAR%20forms%20RSU%20share%20issue%202025.pdf
20251111 - TRMED - MAR forms Scatec Innovations_John Andersen RSU share
transfer.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/18716187/6555/20251111%20-%20TRME
D%20-%20MAR%20forms%20Scatec%20Innovations_John%20Andersen%20RSU%20share%20trans
fer.pdf